Recent developments in understanding the pathophysiology of disordered motor control in cerebral palsy are reviewed. In spastic cerebral palsy, evidence for abnormal segmental as well as supraspinal control of motor neuron output exists. Impaired Ia inhibition of antagonist muscles has been suggested but recently contested. Evidence also supports the role of decreased presynaptic inhibition of Ia afferents and decreased nonreciprocal Ib inhibition. Furthermore, early cerebral injury results in reorganization of supraspinal (corticospinal) inputs to motor neuron pools. In extrapyramidal cerebral palsy, injury of basal ganglia or thalamus has been demonstrated. A scheme for understanding the neurochemical circuitry of the extrapyramidal system is discussed. Animal models and certain specific human diseases provide examples of how this circuitry may be disturbed, thereby resulting in an imbalance between the direct and indirect striatal output systems and in impaired motor control. Future studies employing postmortem neurochemical analysis, functional magnetic resonance imaging, and positron emission tomographic scanning may foster progress in this area. (J Child Neurol 1996;11(Suppl 1):S5-S 12).
Get full access to this article
View all access options for this article.
References
1.
Krageloh-Mann I., Petersen D., Hagberg G., et al: Bilateral spastic cerebral palsy—MRI pathology and origin: Analysis from a representative series of 56 cases. Dev Med Child Neurol1995;37: 379-397.
2.
Kerrigan JF, Chugani HT, Phelps ME: Regional cerebral glucose metabolism in clinical subtypes of cerebral palsy . Pediatr Neurol1991;7:415-425.
3.
Leviton A., Gilles FH: Acquired perinatal leukoencephalopathy. Ann Neurol1984;16:1-8.
4.
Albright AL: Spastic cerebral palsy: Approaches to drug treatment. CNSDrugs1995;4:17-27.
5.
Katz RT, Rymer WZ: Spastic hypertonia: Mechanisms and measurement. Arch Phys Med Rehabil1989;70:144-155.
6.
Young RR, Delwaide PJ: Drug therapy, spasticity (first of two parts). N Engl J Med1981;304:28-33.
7.
Young R.: Spasticity: A review. Neurology1994 ;44(Suppl 9):S12-S20.
8.
Harrison A.: Spastic cerebral palsy: Possible spinal interneuronal contributions . Dev Med Child Neurol1989;30:769-780.
9.
Kandel E, Schwartz JH, Jessell TM (eds): Principles of Neural Science , 3rd ed. New York, Elsevier, 1991.
10.
Hallet M., Alvarez N.: Attempted rapid elbow flexion movements in patients with athetosis . J Neurol Neurosurg Psychiatry1983;46:745-750.
11.
Leonard CT, Moritani T., Hirschfeld H., Forssberg H.: Deficits in reciprocal inhibition of children with cerebral palsy as revealed by H reflex testing. Dev Med Child Neurol1990;32:974-984.
12.
Leonard CT, Hirschfeld H., Moritani T., Forssberg H.: Myotatic reflex development in normal children and children with cerebral palsy. Exp Neurol1991;111:379-382.
13.
Leonard CT: Motor behavior and neural changes following perinatal and adult-onset brain damage: Implications for therapeutic interventions. Phys Ther1994;74:753-767.
14.
Milner-Brown HS, Penn RD: Pathophysiological mechanisms in cerebral palsy. Neurol Neurosurg Psychiatry1979;42:606-618.
15.
Myklebust BM , Gottlieb GL, Penn RD, Agarwal GC: Reciprocal excitation of antagonistic muscles as a differentiating feature in spasticity. Ann Neurol1982; 12:367-374.
16.
Myklebust BM , Gottlieb GL, Agarwal GC: Stretch reflexes of the normal infant. Dev Med Child Neurol1986 ;28:440-449.
17.
Leonard CT, Goldberger ME: Consequences of damage to the sensorimotor cortex in neonatal and adult cats. II. Maintenance of exuberant projections. Dev Brain Res1987;32:15-30.
18.
Berbrayer D. , Ashby P.: Reciprocal inhibition in cerebral palsy. Neurology1990;40:653-656.
19.
Brouwer B., Ashby P.: Do injuries to the developing human brain alter corticospinal projections ? Neurosci Lett1990;108:225-230.
20.
Brouwer B., Ashby P.: Altered corticospinal projections to lower limb motoneurons in subjects with cerebral palsy. Brain1991;114:1395-1407.
21.
Ashby P., Verrier M., Carleton S., Somerville J.: Vibratory inhibition of the monosynaptic reflex and presynaptic inhibition in man, in Feldman RG, Young RR, Koella WP (eds): Spasticity: Disordered Motor Control. London, Year Book, 1980, pp 335-:344.
22.
Iles JF, Roberts RC: Presynaptic inhibition of monosynaptic reflexes in the lower limbs of subjects with upper motoneuron disease. J NeuroL Neurosurg Psychiatry1986;=19:937 -94-1.
23.
Barolat-Romana G., Davis R.: Neurophysiological mechanisms in abnormal reflex activities in cerebral palsy and spinal spasticity. J Neurol Neurosurg Psychiatry1980;43:333-342.
24.
Carr LJ, Harrison LM, Evans AL, Stephens JA: Patterns of central motor reorganization in hemiplegic cerebral palsy . Brain1993;116:1223-1247.
25.
Fanner SF, Harrison LM, Ingram MB, Stephens JA: Plasticity of central motor pathways in children with hemiplegic cerebral palsy. Neurology1991;41:1505-1510.
26.
Cao Y., Vikingstad EM, Huttenlocher PT, et al: Functional magnetic resonance studies of the reorganization of the human hand sensorimotor area after unilateral brain injury in the perinatal period. Proc Natl Acad Sci U S A1994;27:9612-9616.
27.
Kyllerman M. , Bager B., Bensch J., et al: Dyskinetic cerebral palsy. Acta Paediatr Scand1982;71:543-550.
28.
Zeman W., Whitlock CC: Symptomatic dystonias, in Vinken PJ, Bruyn GW (eds): The Handbook of Clinical Neurology, vol 6. Amsterdam , North Holland, 1968, pp 544-566.
29.
Graybiel AM , Ragsdale CW: Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc Natl Acad Sci U S A1978;75: 5723-5726.
30.
Gerfen CR, Engber TM, Mahan LC, et al:. D, and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science1990;250:1429-1432.
31.
Gerfen CR, Keefe KA: Neostriatal dopamine receptors. Z'rends Neurosci1994;17:2-3.
32.
LeMoine C., Normand E., Bloch B.: Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci U S A1991;88:4205-4209.
33.
Walters JR, Bergstrom DA, Carlson JH, et al: D1 receptor activation required for postsynaptic expression of D2 agonist effects. Science1987;236:719-722.
34.
Hallet M.: Physiology of basal ganglia disorders: An overview. Can J Neurol Sci1993;20:177-183.
35.
DeLong MR: Primate models of movement disorders of basal ganglia origin. Trends Neurosci1990;13:281-285.
36.
Bergman H., Wichmann T., DeLong MR: Reversal of experimental parkinsonism by lesions of the subthalamic nucleus . Science1990;249:1436-1438.
37.
Alexander GE , Crutcher MD: Functional architecture of basal ganglia circuits: Neural substrates of parallel processing. Trends Neurosci1990;13:266-271.
38.
Crossman AR , Sambrook MA, Jackson A.: Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia. Brain1984;107:579-596.
39.
Mitchell IJ , Jackson A., Sambrook MA, Crossman AR: Common neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography . Brain Res1985;339:346-350.
40.
Mitchell I. , Sambrook MA, Crossman AR: Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus. Brain1985;108:405-122.
41.
Albin RL, Young AB, Penney JB: The functional anatomy of basal ganglia disorder. Tr-erzds Neurosci1989; 12:366-375.
42.
Albin RI, Reiner A., Anderson KD, et al: Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity-akinesia . Ann Neur-ol1990;27:357-365.
43.
Reiner A., Albin RL, Anderson KD, et al: Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A1988;85:5733-5737.
44.
Storey E., Beal MF: Neurochemical substrates of rigidity and chorea in Huntington's disease . Brain1993; 116:1201-1222.
45.
Friede RL: Developmental Neuropathology. New York, Springer-Verlag, 1975, pp 64-75.
46.
Carpenter MB : Athetosis and the basal ganglia. Arch Neurol Psychiatry1977;63:875-901.
47.
Malamud N., Itabashi HH, Castor J., Messinger HB: An etiologic and diagnostic study of cerebral palsy. J Pediatr1984;65:270-293.
48.
Hayashi M., Satoh J., Sakamoto K., Morimatsu Y.: Clinical and neuropathological findings in severe athetoid cerebral palsy: A comparative study of globo-luysian and thalamo-putaminal groups. Brain Dev1991;13:47-51.
49.
Bhatia KP, Marsden CD: The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain1994;117:859-876.
50.
Yokochi K., Aiba K., Kodama M., Fujimoto S.: Magnetic resonance imaging in athetotic cerebral palsied children . Acta Paediatr Scand1991;80:818-823.
51.
Gascon GG, Ozand PT, Brismar J.: Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations. Brain Dev1994 ;16(Suppl):94-103.
52.
Brismar J., Ozand PT: CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients. Brain Dev1994; 16(Suppl): 104-124.
53.
Turjanski N. , Weeks R., Dolan R., et al: Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas: A PET study. Brain1995;118:689-696.
54.
Rice JE, Vanucci RC, Brierly JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol1981;9: 131-141.
55.
Johnston MV : Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury. Ann Neurol1983;13:511-518.
56.
Kostic VS, Przedborski S., Jackson-Lewis V., et al: Effect of unilateral perinatal hypoxic-ischemic brain injury on striatal dopamine uptake sites and D1 and D2 receptors in adult rats. Neurosci Lett1991;129:197-200; corrigendum, 1991;134:145-149.
57.
Przedborski A., Kostic V., Jackson-Lewis V., et al: Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: A quantitative autoradiographic study. J Neurochem1992;57:1951-1961.
58.
Adair J., Filloux F.: Effect of hypoxic-ischemic brain damage on dopaminergic markers in the neonatal rat: A regional autoradiographic analysis. J Child Neurol1992;7:199-207.
59.
Johnson M., Hanson GR, Gibb JW, et al: Effect of neonatal hypoxia-ischemia on rugro-striata.l dopamine receptors and on striatal neuropeptide Y, dynorphin A and substance P concentrations in rats. Dev Brain Res1994;83:109-118.
60.
Filloux FM, Adair J., Narang N.: The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal ratDev Brain Res , in press.
61.
Ferriero DM , Arcavi LJ, Sagar SM, et al: Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia. Ann Neurol1988;24:670-676.
62.
Medlock MD, Cruse RS, Wmek SJ, et al: A 10-year experience with postpump chorea. Ann Neurol1993;34:820-826.
63.
Kupsky WJ, Drozd MA, Barlow CF: Selective injury of the globus pallidus in children with post-cardiac surgery choreic syndrome. Dev Med Child Neurol1995 ;37:135-144.
Lloyd KG, Hornykiewicz O., Davidson L., et al: Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl JMed1981 ;305:1106-1111.
66.
Jinnah HA, Wojcik BE, Hunt MA, et al: Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci1994;14: 1164-1175.
